| 英文别名 |
17alpha-Hydroxyprogesterone;17alpha-Hydroxypregn-4-ene-3,20-dione;17a-hydroxyprogesterone;hydroxyprogesterone;17-Hydroxyprogesterone;Prodix;Prodox;Gestageno gador;Setaderm;Oxiprogesteronum;17-alpha-Hydroxyprogesterone;Hidroxiprogesterona;Hydroxyprogesteronum;Gestageno;Idrossiprogesterone [DCIT];17alpha-Hydroxy-progesterone;Hydroxyprogesteronum [INN-Latin];Hidroxiprogesterona [INN-;SCHEMBL265609;BCP17647;604-09-1;CID 101793;NS00120929;AKOS025402241;A833616;(8S,9S,10R,13S,14R,17R)-17-Acetyl-17-hydroxy-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one;AC-6839;(8R,9S,10R,13S,14S,17S)-17-acetyl-17-hydroxy-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one;3-(3-Hydroxyphenyl)propionic acid;E78075;17beta-Hydroxyprogesterone;EINECS 210-062-2;DTXSID001313711;(8R,9S,10R,13S,14S,17S)-17-acetyl-17-hydroxy-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one |
